Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
VM.Vthis companyVoyageur Pharmaceuticals Ltd.	CA$0.13	-7.75×	21.82×	2,339.21×	-7.68×	-102.9%	-10466.5%	-30231.6%	-30231.6%	-282.1%	-273.3%	-10.6%	0.03×	0.06×	0×	0.33×	0.0%	5	15.63	2	C
AVCN.TOAvicanna Inc.	CA$0.11	-9.07×	9.08×	1.01×	-12.94×	-14577.3%	50.4%	-10.7%	-11.2%	-100.0%	-22.5%	-5.6%	0×	0.14×	-52.39×	0.86×	0.0%	3	-4.88	2	C
BCT.TOBriaCell Therapeutics Corp.	CA$5.50	-0.68×	1.47×	0×	-0.39×	-83.3%	0.0%	0.0%	0.0%	-216.0%	-234.6%	-120.9%	0×	0.27×	0×	2.76×	0.0%	1	-10.15	2	C
GWAY.CNGreenway Greenhouse Cannabis Corporation	CA$0.08	-8.81×	2.91×	3.02×	82.82×	-4824.0%	2.5%	-19.3%	-34.4%	-33.1%	-6.2%	-8.9%	2.01×	32.35×	-1.17×	0.48×	0.0%	1	-0.99	—	—
IZO.CNIzotropic Corporation	CA$0.13	-9.6×	-3.74×	0×	-16.94×	-159.6%	0.0%	0.0%	0.0%	38.8%	57.4%	-4.1%	-0.55×	-2.05×	-3×	0.06×	0.0%	1	-176.57	2	C
LABS.TOMediPharm Labs Corp.	CA$0.07	-3.32×	0.76×	0.61×	-2.56×	-3416.7%	31.0%	-18.6%	-18.3%	-23.1%	-23.3%	-20.5%	0.01×	1.62×	-133.46×	2.77×	0.0%	3	-2.72	2	C+
Peer median	—	-8.81×	1.47×	0.61×	-2.56×	-3416.7%	2.5%	-10.7%	-11.2%	-33.1%	-22.5%	-8.9%	0×	0.27×	-3×	0.86×	0.0%	1	-4.88	2	—